| GTO ID | GTC2411 |
| Trial ID | NCT04489862 |
| Disease | Lung Non-Small Cell Carcinoma | Mesothelioma |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | αPD1-MSLN-CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors |
| Year | 2020 |
| Country | China |
| Company sponsor | Wuhan Union Hospital, China |
| Other ID(s) | BZDS1901 |
| Cohort 1 | |||||||||||
|
|||||||||||